Cafepharma Today

June 5 2025 - GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
Bispecific cancer drugs, data caveats and funding alarms: 3 takeaways from ASCO
FDA’s Elsa AI is here, and the industry has questions
Merck gains U.S. patent office support in Keytruda dispute
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Cubist Pharma buys out antibiotic partner Astellas for $25M-plus
Fierce Biotech
Monday, March 11, 2013 - 12:34pm
tags:
Cubist Pharma, Astellas, ceftolozane
Aeterna Zentaris to Discontinue Phase 3 Trial in Multiple Myeloma with Perifosine Following Data Safety Monitoring Board Recommendation
Yahoo
Monday, March 11, 2013 - 12:33pm
tags:
Aeterna Zentaris, Multiple Myeloma, perifosine
Vivus investor plots board takeover to rally Qsymia sales
Fierce Pharma
Monday, March 11, 2013 - 12:26pm
tags:
Vivus, Qsymia
3 Undiscovered Biotech Companies For The Healthcare Investor
Seeking Alpha
Monday, March 11, 2013 - 12:25pm
tags:
NeoStem, Antares, Galena Biopharma
PDL BioPharma forecasts greater 1Q royalties
Yahoo/AP
Monday, March 11, 2013 - 12:24pm
tags:
PDL Biopharma
After FDA Approval, A New And Bigger Catalyst Looms Closer For Immunogen
Seeking Alpha
Monday, March 11, 2013 - 11:09am
tags:
Immunogen, trastuzumab, breast cancer
Ziopharm initiates Phase 2 study of Ad-RTLS IL-12
Yahoo/Fly on the Wall
Monday, March 11, 2013 - 11:07am
tags:
Ziopharm, Ad-RTS IL-12, breast cancer
Gilead drug reduces chest pain episodes in diabetics -study
Reuters
Monday, March 11, 2013 - 11:06am
tags:
diabetes, Gilead, angina, Ranexa
Merck KGaA Boosts Stock With Job Cuts Amid Drug Drought
Bloomberg
Monday, March 11, 2013 - 11:04am
tags:
Merck KGaA
Yet Another Negative Trial For Amgen's Aranesp
Forbes
Monday, March 11, 2013 - 11:03am
tags:
Amgen, Aranesp, anemia
New anti-inflammatory causes stir at ACC
Pharma Times, UK
Monday, March 11, 2013 - 11:00am
tags:
anti-inflammatories, Genmab, Roche, inclacumab, angioplasty
Simcere receives buyout offer from founder, ex CEO
Yahoo/AP
Monday, March 11, 2013 - 10:58am
tags:
Simcere, M&A
The Medicines Co's.Cangrelor show favorable results in ischemic events
Yahoo/Fly on the Wall
Monday, March 11, 2013 - 10:56am
tags:
Cangrelor, Medicines Company
AbbVie seeks to stop EU agency releasing drug data
Reuters
Monday, March 11, 2013 - 10:46am
tags:
AbbVie, drug data, EMA, Europe
Is Opko Still A Buy As Frost Continues To Purchase Shares?
Seeking Alpha
Monday, March 11, 2013 - 10:44am
tags:
OPKO Health, Bristol-Myers Squibb, RXi Pharmaceuticals
Discovery Labs Earnings: An Early Look
Motley Fool
Monday, March 11, 2013 - 10:43am
tags:
earnings, Discovery Labs
J&J Faces Second Trial Over Recalled Hip After Loss
Bloomberg
Monday, March 11, 2013 - 10:40am
tags:
recalls, JNJ, hip implants
Study shows superiority of pitavastatin on LDL-C reduction in HIV adults with dyslipidemia
Pharmabiz
Sunday, March 10, 2013 - 12:08pm
tags:
dyslipidemia, Kowa, HIV, Livalo
2 Dow Darlings Boosting Market Health This Week
Wall Street Cheat Street
Sunday, March 10, 2013 - 12:05pm
tags:
Merck, Pfizer
The Best Choice in Healthcare, Period
Motley Fool
Sunday, March 10, 2013 - 12:05pm
tags:
JNJ

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.